Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 25, 2026
Why Is Microsoft (MSFT) Stock Up +3.71% Today?

Why Is Microsoft (MSFT) Stock Up +3.71% Today?

Key Takeaways

  • MSFT shares jumped about +3.71% in afternoon trading, climbing to roughly $516.42 from a prior close of $497.93.
  • The primary catalyst was Microsoft's unveiling of a redesigned Copilot app featuring new "Home," "Code," and always-on "Autopilot" AI agent capabilities.
  • A recent wave of bullish Wall Street calls — including Stifel's upgrade to Buy with a $575 price target — provided a supportive secondary tailwind.
  • Broader AI and semiconductor enthusiasm lifted the technology sector, with Microsoft pacing the "Magnificent Seven" on the day.
  • Traders are now watching Azure cloud growth, Copilot adoption, and the company's next quarterly earnings report for confirmation of the momentum.

Opening Summary

Microsoft Corporation (MSFT), the software, cloud-computing, and artificial-intelligence giant behind Windows, Azure, and the Microsoft 365 productivity suite, surged in today's session as investors cheered fresh product news tied to its AI assistant. The stock was up roughly 3.71% to $516.42 in afternoon trading, versus a previous close of $497.93, putting shares on track for their highest close in more than ten months.

The immediate reason cited by markets was Microsoft's introduction of a new version of its Copilot application, which adds a coding tool, a redesigned home experience, and an "always-on" autonomous AI agent. The move reinforced investor confidence that the company is translating its massive AI investments into tangible, monetizable products.

New Copilot Features Reignite AI Optimism

The day's sharp advance was driven primarily by product news. Microsoft announced a redesigned Copilot experience built around three new core capabilities: Home, a unified starting page that integrates chat and collaboration; Code, a tool that lets users build and safely run custom solutions built on the same underlying technology as GitHub Copilot; and Autopilot, a persistent, proactive AI agent that can continue working even without direct user input.

The update also embeds Word, Excel, and PowerPoint directly into Copilot, allowing users to collaborate across Office applications without leaving the AI tool. Analysts and investors read the rollout as evidence that Copilot is maturing from a chatbot into a broader productivity platform — a key pillar of the bull case for MSFT's long-term growth.

Wall Street Upgrades Provide a Supportive Backdrop

The product announcement landed against a backdrop of increasingly bullish analyst sentiment. Earlier in the week, Stifel upgraded MSFT to Buy from Hold and lifted its price target to $575 from $530, arguing the company has "clearly turned the corner" following its June-quarter earnings report. The firm cited accelerating Azure growth, improved operating efficiency, and rising OpenAI-related revenue as key drivers.

That call followed similar moves from Oppenheimer, which raised its target to $570 while maintaining an Outperform rating, and Cantor Fitzgerald, which lifted its target to $608. With the vast majority of covering analysts now carrying buy-equivalent ratings and no sell ratings, the Street's consensus has turned decidedly positive, giving the stock additional lift.

Market Context and Trading Activity

The rally unfolded amid broader optimism around artificial intelligence. Major U.S. indices opened modestly higher, with the semiconductor sector leading the advance, and Microsoft was cited as the single largest contributor to the S&P 500's gains on the day. Within the "Magnificent Seven," performance was mixed, but MSFT stood out as the clear leader, outpacing peers that traded flat to lower.

The move also carried technical significance. Shares pushed through levels not seen since last year's record territory, and the stock's recent strength has brought it within striking distance of its prior all-time closing high. Elevated participation accompanied the advance, reflecting genuine conviction rather than a thin, low-volume drift.

What Comes Next for MSFT

Looking ahead, investors will be focused on whether Microsoft can sustain its momentum. Key watch items include the pace of Azure revenue acceleration as new data-center capacity comes online, continued Copilot seat growth and monetization, and the trajectory of its OpenAI revenue-sharing arrangement. The rollout of the new Copilot features in the coming weeks — and Autopilot's private preview — will be closely tracked for signs of enterprise adoption.

Risks remain, including persistent questions about the payoff from heavy AI infrastructure spending, potential margin pressure in the cloud business, and the possibility that enterprise IT budgets pull forward demand into late 2026. The company's next quarterly earnings report will be a critical checkpoint for validating the Street's increasingly bullish assumptions.

Trending AI Robots

For traders seeking a data-driven edge, Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, allowing users to explore approaches matched to their own style. Explore the Trending AI Robots to see which automated strategies are currently leading the market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MSFT

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


MSFT sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for MSFT moved above the 200-day moving average on August 28, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 54 cases where MSFT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.

The Momentum Indicator moved above the 0 level on September 21, 2026. You may want to consider a long position or call options on MSFT as a result. In 57 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.

Following a +2.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where MSFT advanced for three days, in 213 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

The Aroon Indicator entered an Uptrend today. In 188 of 279 cases where MSFT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.

Bearish Trend Analysis

The 10-day RSI Indicator for MSFT moved out of overbought territory on August 31, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 16 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 39%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MSFT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

MSFT broke above its upper Bollinger Band on August 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 30 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. MSFT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.361) is normal, around the industry mean (20.511). P/E Ratio (27.740) is within average values for comparable stocks, (160.845). Projected Growth (PEG Ratio) (1.617) is also within normal values, averaging (3.691). Dividend Yield (0.007) settles around the average of (0.004) among similar stocks. P/S Ratio (11.013) is also within normal values, averaging (103.889).

The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), Twilio (NYSE:TWLO), NetApp (NASDAQ:NTAP), Okta (NASDAQ:OKTA), Zscaler (NASDAQ:ZS), MongoDB (NASDAQ:MDB).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 35.38B. The market cap for tickers in the group ranges from 48.8K to 3.72T. MSFT holds the highest valuation in this group at 3.72T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 27%. LHSW experienced the highest price growth at 50%, while HUBC experienced the biggest fall at -55%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -9%. For the same stocks of the Industry, the average monthly volume growth was 25% and the average quarterly volume growth was -16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 70
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 91
Seasonality Score: -12 (-100 ... +100)
View a ticker or compare two or three
MSFT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of software and harware products

Industry ComputerCommunications

Industry
Packaged Software
Address
One Microsoft Way
Phone
+1 425 882-8080
Employees
223000
Web
https://www.microsoft.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.